Federal Court Determines Low Levels of Carcinogens PCE and TCE Insufficient to Establish Private RCRA Cause of Action Absent Expert Testimony

by Blank Rome LLP
Contact

Environmental Litigation

Further underscoring the importance of expert testimony to support environmental claims, the United States District Court for the District of New Jersey in Leese v. Lockheed Martin Corp., et al., No. 11-5091 (JBS/AMD), 2014 U.S. Dist. LEXIS 110889 (D. N.J. Aug. 12, 2014), held that a plaintiff cannot sustain a private cause of action under the Resource Conservation & Recovery Act (“RCRA”), 42 U.S.C. § 6901, et seq., absent sufficient evidence from which a factfinder could conclude that the levels of contamination that are actually present on the plaintiff’s property pose “an imminent and substantial endangerment to health or the environment.” This is so even if the contaminant at issue is considered to be carcinogenic or otherwise hazardous, or was detected at levels above federal or state action levels.

In Leese, the plaintiffs, owners of properties located near a Lockheed Martin research, development, and manufacturing facility, brought an action against Lockheed Martin alleging that the solvents perchloroethylene (“PCE”) and trichloroethylene (“TCE”) were discharged at the facility and migrated offsite into soil and groundwater beneath the plaintiffs’ properties. Both PCE and TCE had been detected on occasion at various concentrations in soil, indoor air, and groundwater samples taken at the plaintiffs’ properties. The plaintiffs sought injunctive relief to prevent and remediate the contamination, as well as civil penalties and attorneys’ fees, under various federal and state statutes, namely, RCRA, the Comprehensive Environmental Response, Compensation & Liability Act (“CERCLA”), 42 U.S.C. § 9601, et seq., the New Jersey Spill Compensation & Control Act (“Spill Act”), N.J.S.A. 58:10-23.11, and the New Jersey Water Pollution Control Act (“WPCA”), N.J.S.A. 58:10A-1, et seq.1

The plaintiffs offered a wealth of evidence to support their statutory claims, including data reflecting detections of PCE and TCE at their properties; a federal regulation deeming TCE and PCE to be “hazardous waste”; printouts from the U.S. Environmental Protection Agency (“EPA”) website describing background exposure levels, reference concentrations, and health hazard information for PCE and TCE; and a “Toxicological Profile for Tetrachloroethylene” by the U.S. Department of Health and Human Services, Public Health Service, Agency for Toxic Substances and Disease Registry (“ATSDR”). The plaintiffs also designated an expert to offer opinions on the subject of “environmental studies and remediation activities conducted at the Lockheed Martin property and nearby residential properties.” Id. at *22. In particular, the expert opined that the PCE and TCE released at the Lockheed Martin facility migrated into groundwater beneath the plaintiffs’ properties, and that the PCE continues to degrade into TCE, migrate into soil vapor through unsaturated soils, and ultimately migrate into air within the plaintiffs’ properties. Critically, while the plaintiffs’ expert offered general opinions regarding the possible health of effects of PCE and TCE—for example, the expert stated that, according to ATSDR and EPA, PCE and TCE affect developmental, neurological, and/or respiratory systems and are reasonably anticipated to be human carcinogens—he did not opine that PCE and TCE pose a substantial risk of harm to health or the environment at the precise levels detected at the plaintiffs’ properties.

In granting summary judgment in favor of Lockheed Martin on the RCRA claim,2 the district court in Leese noted that RCRA requires a plaintiff to show that the contamination poses an imminent and substantial risk of harm to health or the environment at the levels detected at the plaintiff’s property; the mere detection of a hazardous substance, alone, is insufficient. The court concluded that the plaintiffs did not meet their burden because, despite the volume of evidence submitted, all the evidence, “taken together and with all reasonable inferences drawn in favor of Plaintiffs, is insufficient to establish ‘imminent and substantial endangerment.’” Id. at *35. The court reasoned that the plaintiffs’ lone expert did not offer any opinion about the potential risks to health or the environment from exposure to PCE and TCE at the levels detected at the plaintiffs’ properties. Indeed, the expert failed to reference any concentration of PCE or TCE whatsoever in his report, much less the levels at which PCE and TCE are potentially harmful to humans or the environment.

Moreover, the court explained that none of the soil, indoor air, or groundwater samples taken at the plaintiffs’ properties between 2008 and 2012 contained concentrations of PCE or TCE at levels exceeding the current New Jersey Department of Environmental Protection (“NJDEP”) screening levels—the concentrations at which additional testing and monitoring would be required—and the levels of PCE and TCE at the properties were “several orders of magnitude below the EPA’s scientific benchmarks for the threshold of concern for harm to humans.” Id. at *44. In fact, only 6 of 54 samples taken at the plaintiffs’ properties contained PCE or TCE at levels greater than the older, more stringent, NJDEP screening levels. In addition, the levels of PCE and TCE detected at the plaintiffs’ properties steadily declined during that time, suggesting that the contamination was going away.

The Leese court also rejected the plaintiffs’ contention that exposure to PCE and TCE at any level is sufficient to show a substantial risk to health and the environment. To the contrary, according to the court, the relevant scientific benchmarks for PCE and TCE—i.e., the reference concentrations, reference exposure levels, references doses, and screening levels set by regulatory agencies such as EPA and NJDEP as the thresholds of concern for harm to humans—suggest that lower, trace concentrations of PCE and TCE can be tolerated and do not pose a substantial risk of harm to health or the environment. Because the plaintiffs offered “no evidence and no expert testimony that TCE or PCE may pose a substantial risk of harm to health or the environment at levels detected on and around Plaintiffs’ properties,” the court in Leese granted summary judgment for Lockheed Martin on the RCRA claim. Id. at *35, 48-49.

Leese does not stand for the proposition that the presence of a contaminant at levels below federal or state action levels could never amount to an imminent and substantial threat to health or the environment for purposes of RCRA liability. Indeed, the court in Leese expressly cautioned against such a bright-line interpretation, stating:

In so holding, the Court does not find as a matter of law that TCE and PCE at levels below the NJDEP screening levels could never pose a threat to health or the environment. Similarly, the Court does not hold that concentrations of TCE and PCE below the EPA or other risk level thresholds could never be potentially harmful to health or the environment. Plaintiffs simply have not carried their burden to adduce evidence to permit a reasonable inference that this is so, and the Court is aware of no basis for assuming that the mere presence of these low levels of TCE and PCE may pose a risk of substantial and imminent harm, given that the present EPA risk thresholds are set at much higher concentrations before concern for potential health effects is justified.

Id. at *48.

Certainly, however, action levels will serve as useful guideposts to determine whether an imminent and substantial endangerment to health or the environment exists. For example, a plaintiff may be able to satisfy its burden under RCRA if federal or state regulators have established a threshold at which a substance poses a threat to health and, unlike in Leese, the plaintiff presents evidence that the substance was detected at the property above that threshold consistently over time and at increasing concentrations. On the other hand, a more difficult case exists where concentrations of a substance are below applicable regulatory action levels and have exhibited a declining pattern.

At bottom, Leese is a lesson for plaintiffs that quality, not quantity, is paramount for purposes of establishing a claim under RCRA. Volumes of testing data reflecting the presence of a contaminant at one’s property and scientific authority concluding that a contaminant is hazardous to human health are of no consequence unless a plaintiff comes forward with specific, pointed evidence showing that the contaminant is potentially harmful to health or the environment at the levels that are actually detected at the plaintiff’s property. In most instances, this type of showing must be made through the testimony of an expert, such as a toxicologist, who analyzes the specific concentrations that are present in the context of regulatory thresholds and existing toxicological and scientific literature.

  1. The plaintiffs also asserted common law claims against Lockheed Martin. In a prior opinion, the court granted partial summary judgment in favor of Lockheed Martin on those claims because the plaintiffs failed to produce adequate evidence of bodily injury (lack of causation) and diminution of property value.
  2. The court also granted summary judgment for Lockheed Martin on the Spill Act and the WPCA claims because the plaintiffs failed to provide notice to certain parties before commencing their lawsuit as required by the New Jersey Environmental Rights Act, N.J.S.A. 2A:35A-1, et seq., under and through which the plaintiffs brought their Spill Act and WPCA claims. In addition, the court granted summary judgment for Lockheed Martin on the CERCLA claim because the plaintiffs did not present arguments or evidence to support a claim for response costs incurred before filing suit.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Blank Rome LLP | Attorney Advertising

Written by:

Blank Rome LLP
Contact
more
less

Blank Rome LLP on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up using*

Already signed up? Log in here

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
Privacy Policy (Updated: October 8, 2015):
hide

JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources. Our policies with regard to data collection and use of personal information of users of the Service, regardless of the manner in which users access the Service, and visitors to the Website are set forth in this statement ("Policy"). By using the Service, you signify your acceptance of this Policy.

Information Collection and Use by JD Supra

JD Supra collects users' names, companies, titles, e-mail address and industry. JD Supra also tracks the pages that users visit, logs IP addresses and aggregates non-personally identifiable user data and browser type. This data is gathered using cookies and other technologies.

The information and data collected is used to authenticate users and to send notifications relating to the Service, including email alerts to which users have subscribed; to manage the Service and Website, to improve the Service and to customize the user's experience. This information is also provided to the authors of the content to give them insight into their readership and help them to improve their content, so that it is most useful for our users.

JD Supra does not sell, rent or otherwise provide your details to third parties, other than to the authors of the content on JD Supra.

If you prefer not to enable cookies, you may change your browser settings to disable cookies; however, please note that rejecting cookies while visiting the Website may result in certain parts of the Website not operating correctly or as efficiently as if cookies were allowed.

Email Choice/Opt-out

Users who opt in to receive emails may choose to no longer receive e-mail updates and newsletters by selecting the "opt-out of future email" option in the email they receive from JD Supra or in their JD Supra account management screen.

Security

JD Supra takes reasonable precautions to insure that user information is kept private. We restrict access to user information to those individuals who reasonably need access to perform their job functions, such as our third party email service, customer service personnel and technical staff. However, please note that no method of transmitting or storing data is completely secure and we cannot guarantee the security of user information. Unauthorized entry or use, hardware or software failure, and other factors may compromise the security of user information at any time.

If you have reason to believe that your interaction with us is no longer secure, you must immediately notify us of the problem by contacting us at info@jdsupra.com. In the unlikely event that we believe that the security of your user information in our possession or control may have been compromised, we may seek to notify you of that development and, if so, will endeavor to do so as promptly as practicable under the circumstances.

Sharing and Disclosure of Information JD Supra Collects

Except as otherwise described in this privacy statement, JD Supra will not disclose personal information to any third party unless we believe that disclosure is necessary to: (1) comply with applicable laws; (2) respond to governmental inquiries or requests; (3) comply with valid legal process; (4) protect the rights, privacy, safety or property of JD Supra, users of the Service, Website visitors or the public; (5) permit us to pursue available remedies or limit the damages that we may sustain; and (6) enforce our Terms & Conditions of Use.

In the event there is a change in the corporate structure of JD Supra such as, but not limited to, merger, consolidation, sale, liquidation or transfer of substantial assets, JD Supra may, in its sole discretion, transfer, sell or assign information collected on and through the Service to one or more affiliated or unaffiliated third parties.

Links to Other Websites

This Website and the Service may contain links to other websites. The operator of such other websites may collect information about you, including through cookies or other technologies. If you are using the Service through the Website and link to another site, you will leave the Website and this Policy will not apply to your use of and activity on those other sites. We encourage you to read the legal notices posted on those sites, including their privacy policies. We shall have no responsibility or liability for your visitation to, and the data collection and use practices of, such other sites. This Policy applies solely to the information collected in connection with your use of this Website and does not apply to any practices conducted offline or in connection with any other websites.

Changes in Our Privacy Policy

We reserve the right to change this Policy at any time. Please refer to the date at the top of this page to determine when this Policy was last revised. Any changes to our privacy policy will become effective upon posting of the revised policy on the Website. By continuing to use the Service or Website following such changes, you will be deemed to have agreed to such changes. If you do not agree with the terms of this Policy, as it may be amended from time to time, in whole or part, please do not continue using the Service or the Website.

Contacting JD Supra

If you have any questions about this privacy statement, the practices of this site, your dealings with this Web site, or if you would like to change any of the information you have provided to us, please contact us at: info@jdsupra.com.

- hide
*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.